Effects of Empagliflozin in Reducing Oxidative Stress After Kidney Transplantation

NCT04918407 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Kidney Transplant; Complications

Interventions

DRUG: Empagliflozin 25 MG
DRUG: Insulin

Sponsor

Shahid Beheshti University of Medical Sciences